यूरोपीय संघ - स्लोवाक - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

यूरोपीय संघ - स्लोवाक - EMA (European Medicines Agency)

axunio pharma gmbh - pirfenidone - idiopatická pľúcna fibróza - imunosupresíva - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

यूरोपीय संघ - स्लोवाक - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresíva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

यूरोपीय संघ - स्लोवाक - EMA (European Medicines Agency)

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

यूरोपीय संघ - स्लोवाक - EMA (European Medicines Agency)

janssen-cilag international n.v. - paliperidón palmitát - schizofrénie - psycholeptika - xeplion je indikovaný na udržiavaciu liečbu schizofrénie u dospelých pacientov stabilizovaných paliperidónom alebo risperidónom. in selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, xeplion may be used without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate and a long-acting injectable treatment is needed.

यूरोपीय संघ - स्लोवाक - EMA (European Medicines Agency)

janssen-cilag international nv - guselkumab - svrab - imunosupresíva - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.

स्लोवाकिया - स्लोवाक - ŠÚKL (Štátny ústav pre kontrolu liečiv)

research and production company "dinamika" ltd. ^ 16 moskovskoe street 196158 saint petersburg ruská federácia -

स्लोवाकिया - स्लोवाक - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - atorvastatín - 31 - hypolipidaemica

स्लोवाकिया - स्लोवाक - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - atorvastatín - 31 - hypolipidaemica

स्लोवाकिया - स्लोवाक - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - atorvastatín - 31 - hypolipidaemica